Tapewire

Nasdaq · USD

AMRX

Amneal Pharmaceuticals, Inc.

Export transactions ↓
Tapewire entity
820
SEC CIK
0001723128
Parsed reports
351

Last 12 months

Inside the activity.

0 purchase rows · 7 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202604
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 03, 2024 Filed Mar 5, 2024 21:35 UTC
Shah NikitaExecutive Vice President
Exercise / conversionRestricted Stock Units · Derivative 36,232 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-008945 · wk-form4_1709674499.xml · derivative · entry 8

Shah Nikita · CIK 0001738061 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,464

Underlying: Class A Common Stock · 36,232 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F5 · derivative.exercise_date: On March 3, 2022, the reporting person was granted 144,928 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

F5 · derivative.expiration_date: On March 3, 2022, the reporting person was granted 144,928 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

Read SEC document
March 03, 2024 Filed Mar 5, 2024 21:35 UTC
Shah NikitaExecutive Vice President
Tax withholdingClass A Common Stock 22,982 $5.47 $125,711.54
Disclosure

SEC source: 0001628280-24-008945 · wk-form4_1709674499.xml · nonDerivative · entry 6

Shah Nikita · CIK 0001738061 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 391,666

F3 · shares: Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.

Read SEC document
March 03, 2024 Filed Mar 5, 2024 21:35 UTC
Shah NikitaExecutive Vice President
Exercise / conversionClass A Common Stock 45,871 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-24-008945 · wk-form4_1709674499.xml · nonDerivative · entry 5

Shah Nikita · CIK 0001738061 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 414,648

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the gross number of shares of common stock issuable to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
March 03, 2024 Filed Mar 5, 2024 21:35 UTC
Shah NikitaExecutive Vice President
Tax withholdingClass A Common Stock 18,153 $5.47 $99,296.91
Disclosure

SEC source: 0001628280-24-008945 · wk-form4_1709674499.xml · nonDerivative · entry 4

Shah Nikita · CIK 0001738061 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 368,777

F3 · shares: Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.

Read SEC document
March 03, 2024 Filed Mar 5, 2024 21:35 UTC
Shah NikitaExecutive Vice President
Exercise / conversionClass A Common Stock 36,232 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-24-008945 · wk-form4_1709674499.xml · nonDerivative · entry 3

Shah Nikita · CIK 0001738061 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 386,930

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the gross number of shares of common stock issuable to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:56 UTC
Konidaris TasosExecutive Vice President & CFO
Exercise / conversionRestricted Stock Units · Derivative 36,197 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-008979 · wk-form4_1709675759.xml · derivative · entry 7

Konidaris Tasos · CIK 0001320982 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,197

Underlying: Class A Common Stock · 36,197 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: On March 1, 2021, the reporting person was granted 144,788 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

F4 · derivative.expiration_date: On March 1, 2021, the reporting person was granted 144,788 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:56 UTC
Konidaris TasosExecutive Vice President & CFO
Tax withholdingClass A Common Stock 13,257 $5.47 $72,515.79
Disclosure

SEC source: 0001628280-24-008979 · wk-form4_1709675759.xml · nonDerivative · entry 2

Konidaris Tasos · CIK 0001320982 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 403,780

F3 · shares: Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:56 UTC
Konidaris TasosExecutive Vice President & CFO
Exercise / conversionClass A Common Stock 36,197 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-24-008979 · wk-form4_1709675759.xml · nonDerivative · entry 1

Konidaris Tasos · CIK 0001320982 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 417,037

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:40 UTC
BOYER ANDREW SExecutive Vice President
Exercise / conversionRestricted Stock Units · Derivative 31,371 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-008951 · wk-form4_1709674816.xml · derivative · entry 7

BOYER ANDREW S · CIK 0001239546 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,371

Underlying: Class A Common Stock · 31,371 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: On March 1, 2021, the reporting person was granted 125,483 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

F4 · derivative.expiration_date: On March 1, 2021, the reporting person was granted 125,483 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:40 UTC
BOYER ANDREW SExecutive Vice President
Tax withholdingClass A Common Stock 16,219 $5.47 $88,717.93
Disclosure

SEC source: 0001628280-24-008951 · wk-form4_1709674816.xml · nonDerivative · entry 2

BOYER ANDREW S · CIK 0001239546 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 274,998

F3 · shares: Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:40 UTC
BOYER ANDREW SExecutive Vice President
Exercise / conversionClass A Common Stock 31,371 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-24-008951 · wk-form4_1709674816.xml · nonDerivative · entry 1

BOYER ANDREW S · CIK 0001239546 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 291,217

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:35 UTC
Shah NikitaExecutive Vice President
Exercise / conversionRestricted Stock Units · Derivative 28,957 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-008945 · wk-form4_1709674499.xml · derivative · entry 7

Shah Nikita · CIK 0001738061 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,958

Underlying: Class A Common Stock · 28,957 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: March 1, 2021, the reporting person was granted 115,830 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

F4 · derivative.expiration_date: March 1, 2021, the reporting person was granted 115,830 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:35 UTC
Shah NikitaExecutive Vice President
Tax withholdingClass A Common Stock 15,181 $5.47 $83,040.07
Disclosure

SEC source: 0001628280-24-008945 · wk-form4_1709674499.xml · nonDerivative · entry 2

Shah Nikita · CIK 0001738061 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 350,698

F3 · shares: Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:35 UTC
Shah NikitaExecutive Vice President
Exercise / conversionClass A Common Stock 28,957 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-24-008945 · wk-form4_1709674499.xml · nonDerivative · entry 1

Shah Nikita · CIK 0001738061 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 365,879

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the gross number of shares of common stock issuable to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 21:26 UTC
BOYER ANDREW SExecutive Vice President
Exercise / conversionRestricted Stock Units · Derivative 31,663 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-007998 · wk-form4_1709241999.xml · derivative · entry 3

BOYER ANDREW S · CIK 0001239546 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 31,663 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: On February 27, 2020, the reporting person was granted 126,649 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

F4 · derivative.expiration_date: On February 27, 2020, the reporting person was granted 126,649 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 21:26 UTC
BOYER ANDREW SExecutive Vice President
Tax withholdingClass A Common Stock 16,556 $5.71 $94,534.76
Disclosure

SEC source: 0001628280-24-007998 · wk-form4_1709241999.xml · nonDerivative · entry 2

BOYER ANDREW S · CIK 0001239546 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 259,846

F3 · shares: Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 21:26 UTC
BOYER ANDREW SExecutive Vice President
Exercise / conversionClass A Common Stock 31,663 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-24-007998 · wk-form4_1709241999.xml · nonDerivative · entry 1

BOYER ANDREW S · CIK 0001239546 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 276,402

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 21:25 UTC
Shah NikitaExecutive Vice President
Exercise / conversionRestricted Stock Units · Derivative 35,620 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-007994 · wk-form4_1709241939.xml · derivative · entry 3

Shah Nikita · CIK 0001738061 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 35,620 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: On February 27, 2020, the reporting person was granted 142,480 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

F4 · derivative.expiration_date: On February 27, 2020, the reporting person was granted 142,480 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 21:25 UTC
Shah NikitaExecutive Vice President
Tax withholdingClass A Common Stock 18,670 $5.71 $106,605.70
Disclosure

SEC source: 0001628280-24-007994 · wk-form4_1709241939.xml · nonDerivative · entry 2

Shah Nikita · CIK 0001738061 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 336,922

F3 · shares: Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 21:25 UTC
Shah NikitaExecutive Vice President
Exercise / conversionClass A Common Stock 35,620 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-24-007994 · wk-form4_1709241939.xml · nonDerivative · entry 1

Shah Nikita · CIK 0001738061 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 355,592

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 21:36 UTC
Patel GautamDirector
GiftClass A Common Stock 1,598,115 $0.00 $0.00
Disclosure

SEC source: 0000898432-24-000011 · form4.xml · nonDerivative · entry 2

Patel Gautam · CIK 0001738054 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,972,433

F2 · kind: The reporting person is a beneficiary of one of the Trusts. Following the execution of the transactions described in the preceding footnote, on January 1, 2024, the reporting person received a distribution from such Trust of 1,598,115 shares of the Class A Common Stock of the issuer.

Read SEC document
January 01, 2024 Filed Jan 3, 2024 21:36 UTC
Patel GautamDirector
OtherClass A Common Stock 33,458,067 Not disclosed Not disclosed
Disclosure

SEC source: 0000898432-24-000011 · form4.xml · nonDerivative · entry 1

Patel Gautam · CIK 0001738054 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 374,318

F1 · kind: The reporting person previously controlled an entity (the "Trustee") that serves as the sole trustee of certain trusts (the "Trusts") that hold, in the aggregate, 33,458,067 shares of the Class A Common Stock of the issuer. On January 1, 2024, the reporting person sold to a third party all of the issued and outstanding common stock of the Trustee. In connection therewith, the reporting person also resigned from all positions he previously held with the Trustee, effective as of January 1, 2024. As a result of these transactions, the reporting person no longer has beneficial ownership of any of the shares of Class A Common Stock of the issuer held by any trusts of which the Trustee is the sole trustee.

F1 · price: The reporting person previously controlled an entity (the "Trustee") that serves as the sole trustee of certain trusts (the "Trusts") that hold, in the aggregate, 33,458,067 shares of the Class A Common Stock of the issuer. On January 1, 2024, the reporting person sold to a third party all of the issued and outstanding common stock of the Trustee. In connection therewith, the reporting person also resigned from all positions he previously held with the Trustee, effective as of January 1, 2024. As a result of these transactions, the reporting person no longer has beneficial ownership of any of the shares of Class A Common Stock of the issuer held by any trusts of which the Trustee is the sole trustee.

Read SEC document
November 07, 2023 Filed Nov 8, 2023 23:20 UTC
Patel ChintuDirector · Co-CEO
OtherClass B Common Stock and Common Units · Derivative 24,753,252 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-054738 · doc4.xml · derivative · entry 3

Patel Chintu · CIK 0001737428 · Director · Co-CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trusts

Disclosed balance after: 0

Underlying: Class A Common Stock · 24,753,252 shares

Expires not disclosed

F3 · security: The Issuer of the Common Units is Amneal Pharmaceuticals, LLC.

F2 · derivative.exercise_price: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

F2 · price: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

F2 · derivative.exercise_date: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

F2 · derivative.expiration_date: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

Read SEC document
November 07, 2023 Filed Nov 8, 2023 23:20 UTC
Patel ChintuDirector · Co-CEO
OtherClass A Common Stock 24,753,252 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-054738 · doc4.xml · nonDerivative · entry 1

Patel Chintu · CIK 0001737428 · Director · Co-CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trusts

Disclosed balance after: 24,753,252

F1 · security: On November 7, 2023, Amneal Pharmaceuticals, Inc. (formerly known as Amneal NewCo Inc.) (the "Issuer") became the successor of Amneal Intermediate Inc. (formerly known as Amneal Pharmaceuticals, Inc.) ("Old PubCo") pursuant to merger transactions, in which a subsidiary of the Issuer merged with and into Old PubCo with Old PubCo surviving and, immediately following such merger, a subsidiary of the Issuer merged with and into Amneal Pharmaceuticals, LLC ("AP"), an indirect subsidiary of the Issuer, with AP surviving. The transactions resulted in the Issuer becoming a parent holding company of Old PubCo and AP. As a result of the transactions, there is a single class of stock of the Issuer outstanding, and the proportionate economic and voting rights of security holders in the Issuer are identical to the direct and indirect economic and voting rights held in Old PubCo and AP prior to the transactions.

F2 · price: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

Read SEC document
November 07, 2023 Filed Nov 8, 2023 23:22 UTC OtherClass B Common Stock and Common Units · Derivative 53,578,209 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-054742 · doc4.xml · derivative · entry 2

Patel Tushar Bhikhubhai · CIK 0001745375 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trusts

Disclosed balance after: 0

Underlying: Class A Common Stock · 53,578,209 shares

Expires not disclosed

F3 · security: The Issuer of the Common Units is Amneal Pharmaceuticals, LLC.

F2 · derivative.exercise_price: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

F2 · price: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

F2 · derivative.exercise_date: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

F2 · derivative.expiration_date: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

Read SEC document
November 07, 2023 Filed Nov 8, 2023 23:22 UTC OtherClass A Common Stock 53,578,209 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-054742 · doc4.xml · nonDerivative · entry 1

Patel Tushar Bhikhubhai · CIK 0001745375 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trusts

Disclosed balance after: 53,578,209

F1 · security: On November 7, 2023, Amneal Pharmaceuticals, Inc. (formerly known as Amneal NewCo Inc.) (the "Issuer") became the successor of Amneal Intermediate Inc. (formerly known as Amneal Pharmaceuticals, Inc.) ("Old PubCo") pursuant to merger transactions, in which a subsidiary of the Issuer merged with and into Old PubCo with Old PubCo surviving and, immediately following such merger, a subsidiary of the Issuer merged with and into Amneal Pharmaceuticals, LLC ("AP"), an indirect subsidiary of the Issuer, with AP surviving. The transactions resulted in the Issuer becoming a parent holding company of Old PubCo and AP. As a result of the transactions, there is a single class of stock of the Issuer outstanding, and the proportionate economic and voting rights of security holders in the Issuer are identical to the direct and indirect economic and voting rights held in Old PubCo and AP prior to the transactions.

F2 · price: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

Read SEC document
November 07, 2023 Filed Nov 8, 2023 23:20 UTC
Patel Chirag K.Director · President & Co-CEO
OtherClass B Common Stock and Common Units · Derivative 21,269,420 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-054739 · doc4.xml · derivative · entry 3

Patel Chirag K. · CIK 0001738701 · Director · President & Co-CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trusts

Disclosed balance after: 0

Underlying: Class A Common Stock · 21,269,420 shares

Expires not disclosed

F3 · security: The Issuer of the Common Units is Amneal Pharmaceuticals, LLC.

F2 · derivative.exercise_price: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

F2 · price: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

F2 · derivative.exercise_date: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

F2 · derivative.expiration_date: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

Read SEC document
November 07, 2023 Filed Nov 8, 2023 23:20 UTC
Patel Chirag K.Director · President & Co-CEO
OtherClass A Common Stock 21,269,420 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-054739 · doc4.xml · nonDerivative · entry 1

Patel Chirag K. · CIK 0001738701 · Director · President & Co-CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trusts

Disclosed balance after: 21,269,420

F1 · security: On November 7, 2023, Amneal Pharmaceuticals, Inc. (formerly known as Amneal NewCo Inc.) (the "Issuer") became the successor of Amneal Intermediate Inc. (formerly known as Amneal Pharmaceuticals, Inc.) ("Old PubCo") pursuant to merger transactions, in which a subsidiary of the Issuer merged with and into Old PubCo with Old PubCo surviving and, immediately following such merger, a subsidiary of the Issuer merged with and into Amneal Pharmaceuticals, LLC ("AP"), an indirect subsidiary of the Issuer, with AP surviving. The transactions resulted in the Issuer becoming a parent holding company of Old PubCo and AP. As a result of the transactions, there is a single class of stock of the Issuer outstanding, and the proportionate economic and voting rights of security holders in the Issuer are identical to the direct and indirect economic and voting rights held in Old PubCo and AP prior to the transactions.

F2 · price: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

Read SEC document
November 07, 2023 Filed Nov 8, 2023 23:21 UTC
Patel GautamDirector · 10% owner
OtherClass B Common Stock and Common Units · Derivative 17,497,336 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-054741 · doc4.xml · derivative · entry 3

Patel Gautam · CIK 0001738054 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Class A Common Stock · 17,497,336 shares

Expires not disclosed

F4 · security: The Issuer of the Common Units is Amneal Pharmaceuticals, LLC.

F2 · derivative.exercise_price: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

F2 · price: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

F2 · derivative.exercise_date: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

F2 · derivative.expiration_date: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

F3 · ownership.nature: By trusts which the reporting person may be deemed to control. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Read SEC document
November 07, 2023 Filed Nov 8, 2023 23:21 UTC
Patel GautamDirector · 10% owner
OtherClass A Common Stock 17,497,336 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-054741 · doc4.xml · nonDerivative · entry 1

Patel Gautam · CIK 0001738054 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 30,384,769

F1 · security: On November 7, 2023, Amneal Pharmaceuticals, Inc. (formerly known as Amneal NewCo Inc.) (the "Issuer") became the successor of Amneal Intermediate Inc. (formerly known as Amneal Pharmaceuticals, Inc.) ("Old PubCo") pursuant to merger transactions, in which a subsidiary of the Issuer merged with and into Old PubCo with Old PubCo surviving and, immediately following such merger, a subsidiary of the Issuer merged with and into Amneal Pharmaceuticals, LLC ("AP"), an indirect subsidiary of the Issuer, with AP surviving. The transactions resulted in the Issuer becoming a parent holding company of Old PubCo and AP. As a result of the transactions, there is a single class of stock of the Issuer outstanding, and the proportionate economic and voting rights of security holders in the Issuer are identical to the direct and indirect economic and voting rights held in Old PubCo and AP prior to the transactions.

F2 · price: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

F3 · ownership.nature: By trusts which the reporting person may be deemed to control. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Read SEC document
November 07, 2023 Filed Nov 8, 2023 23:21 UTC
Patel DipanMember of 13D Group
OtherClass B Common Stock and Common Units · Derivative 26,905,073 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-054740 · doc4.xml · derivative · entry 2

Patel Dipan · CIK 0001745437 · Member of 13D Group

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trusts

Disclosed balance after: 0

Underlying: Class A Common Stock · 26,905,073 shares

Expires not disclosed

F3 · security: The Issuer of the Common Units is Amneal Pharmaceuticals, LLC.

F2 · derivative.exercise_price: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

F2 · price: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

F2 · derivative.exercise_date: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

F2 · derivative.expiration_date: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

Read SEC document
November 07, 2023 Filed Nov 8, 2023 23:21 UTC
Patel DipanMember of 13D Group
OtherClass A Common Stock 26,905,073 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-054740 · doc4.xml · nonDerivative · entry 1

Patel Dipan · CIK 0001745437 · Member of 13D Group

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trusts

Disclosed balance after: 26,905,073

F1 · security: On November 7, 2023, Amneal Pharmaceuticals, Inc. (formerly known as Amneal NewCo Inc.) (the "Issuer") became the successor of Amneal Intermediate Inc. (formerly known as Amneal Pharmaceuticals, Inc.) ("Old PubCo") pursuant to merger transactions, in which a subsidiary of the Issuer merged with and into Old PubCo with Old PubCo surviving and, immediately following such merger, a subsidiary of the Issuer merged with and into Amneal Pharmaceuticals, LLC ("AP"), an indirect subsidiary of the Issuer, with AP surviving. The transactions resulted in the Issuer becoming a parent holding company of Old PubCo and AP. As a result of the transactions, there is a single class of stock of the Issuer outstanding, and the proportionate economic and voting rights of security holders in the Issuer are identical to the direct and indirect economic and voting rights held in Old PubCo and AP prior to the transactions.

F2 · price: Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration.

Read SEC document
August 11, 2023 Filed Aug 15, 2023 20:30 UTC
BOYER ANDREW SExecutive Vice President
SaleClass A Common Stock 29,302 $4.13 $120,920.56
Disclosure

SEC source: 0001209191-23-045846 · doc4.xml · nonDerivative · entry 1

BOYER ANDREW S · CIK 0001239546 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 244,739

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.94 to $4.22, inclusive. The reporting person undertakes to provide to Amneal Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
July 30, 2023 Filed Aug 1, 2023 20:30 UTC Exercise / conversionRestricted Stock Units · Derivative 54,949 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-043988 · doc4.xml · derivative · entry 2

Autor Deborah M. · CIK 0001884671 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 54,949 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: On July 29, 2022 the reporting person was granted 54,949 restricted stock units vesting on July 30, 2023.

F2 · derivative.expiration_date: On July 29, 2022 the reporting person was granted 54,949 restricted stock units vesting on July 30, 2023.

Read SEC document
July 30, 2023 Filed Aug 1, 2023 20:30 UTC Exercise / conversionClass A Common Stock 54,949 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-043988 · doc4.xml · nonDerivative · entry 1

Autor Deborah M. · CIK 0001884671 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,949

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
June 30, 2023 Filed Jul 5, 2023 20:30 UTC
BOYER ANDREW SExecutive Vice President
Exercise / conversionRestricted Stock Units · Derivative 23,095 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-041087 · doc4.xml · derivative · entry 3

BOYER ANDREW S · CIK 0001239546 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 23,095 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: On August 1, 2020, the reporting person was granted 69,284 restricted stock units vesting in three equal installments beginning on June 30, 2021.

F4 · derivative.expiration_date: On August 1, 2020, the reporting person was granted 69,284 restricted stock units vesting in three equal installments beginning on June 30, 2021.

Read SEC document
June 30, 2023 Filed Jul 5, 2023 20:30 UTC
BOYER ANDREW SExecutive Vice President
Tax withholdingClass A Common Stock 11,571 $3.10 $35,870.10
Disclosure

SEC source: 0001209191-23-041087 · doc4.xml · nonDerivative · entry 2

BOYER ANDREW S · CIK 0001239546 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 274,041

F3 · shares: Represents shares of Class A Common Stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.

Read SEC document
June 30, 2023 Filed Jul 5, 2023 20:30 UTC
BOYER ANDREW SExecutive Vice President
Exercise / conversionClass A Common Stock 23,095 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-041087 · doc4.xml · nonDerivative · entry 1

BOYER ANDREW S · CIK 0001239546 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 285,612

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the gross number of shares of Class A Common Stock, par value $0.01 per share (the "Class A Common Stock") issuable to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
May 10, 2023 Filed May 11, 2023 20:15 UTC Exercise / conversionRestricted Stock Units · Derivative 112,179 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-028730 · doc4.xml · derivative · entry 3

MEISTER PAUL M · CIK 0001033876 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 112,179 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: On May 9, 2022 the reporting person was granted 112,179 restricted stock units vesting on May 10, 2023.

F3 · derivative.expiration_date: On May 9, 2022 the reporting person was granted 112,179 restricted stock units vesting on May 10, 2023.

Read SEC document
May 10, 2023 Filed May 11, 2023 20:15 UTC Exercise / conversionClass A Common Stock 112,179 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-028730 · doc4.xml · nonDerivative · entry 1

MEISTER PAUL M · CIK 0001033876 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 620,658

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
May 10, 2023 Filed May 11, 2023 20:15 UTC Exercise / conversionRestricted Stock Units · Derivative 80,128 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-028729 · doc4.xml · derivative · entry 3

George Jeffrey P. · CIK 0001796789 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 80,128 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023.

F3 · derivative.expiration_date: On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023.

Read SEC document
May 10, 2023 Filed May 11, 2023 20:15 UTC Exercise / conversionClass A Common Stock 80,128 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-028729 · doc4.xml · nonDerivative · entry 1

George Jeffrey P. · CIK 0001796789 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 193,084

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
May 10, 2023 Filed May 11, 2023 20:15 UTC
Kiely JohnDirector
Exercise / conversionRestricted Stock Units · Derivative 80,128 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-028735 · doc4.xml · derivative · entry 3

Kiely John · CIK 0001781149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 80,128 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023.

F3 · derivative.expiration_date: On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023.

Read SEC document
May 10, 2023 Filed May 11, 2023 20:15 UTC
Kiely JohnDirector
Exercise / conversionClass A Common Stock 80,128 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-028735 · doc4.xml · nonDerivative · entry 1

Kiely John · CIK 0001781149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,274

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
May 10, 2023 Filed May 11, 2023 16:15 UTC Exercise / conversionRestricted Stock Units · Derivative 80,128 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-028737 · doc4.xml · derivative · entry 3

Alva Emily Peterson · CIK 0001738422 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 80,128 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023.

F3 · derivative.expiration_date: On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023.

Read SEC document
May 10, 2023 Filed May 11, 2023 16:15 UTC Exercise / conversionClass A Common Stock 80,128 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-028737 · doc4.xml · nonDerivative · entry 1

Alva Emily Peterson · CIK 0001738422 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,318

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
May 10, 2023 Filed May 11, 2023 20:15 UTC
Yanai ShlomoDirector
Exercise / conversionRestricted Stock Units · Derivative 80,128 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-028732 · doc4.xml · derivative · entry 3

Yanai Shlomo · CIK 0001562645 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 80,128 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023.

F3 · derivative.expiration_date: On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023.

Read SEC document
May 10, 2023 Filed May 11, 2023 20:15 UTC
Yanai ShlomoDirector
Exercise / conversionClass A Common Stock 80,128 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-028732 · doc4.xml · nonDerivative · entry 1

Yanai Shlomo · CIK 0001562645 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 169,274

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document
May 10, 2023 Filed May 11, 2023 20:15 UTC
Patel GautamDirector
Exercise / conversionRestricted Stock Units · Derivative 80,128 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-028733 · doc4.xml · derivative · entry 4

Patel Gautam · CIK 0001738054 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 80,128 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023.

F4 · derivative.expiration_date: On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023.

Read SEC document
May 10, 2023 Filed May 11, 2023 20:15 UTC
Patel GautamDirector
Exercise / conversionClass A Common Stock 80,128 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-028733 · doc4.xml · nonDerivative · entry 1

Patel Gautam · CIK 0001738054 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 374,318

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.